National Research Corporation

National Research Corporation

NRC·NASDAQ

$19.04

-2.8%
HealthcareMedical - Healthcare Information Services

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

At a Glance

Live Snapshot
Market Cap$429.10M
EPS0.5200
P/E Ratio36.62
Earnings Date07/27/2026
14.36%
Return on Invested Capital
-45%
3Y-57.0%
5Y-60.0%
10Y-35.0%
82.92%
Return on Equity
5%
3Y+88.0%
5Y+43.0%
10Y+235.0%
8.60%
Return on Assets
-54%
3Y-65.0%
5Y-69.0%
10Y-49.0%
National Research Corporation

National Research Corporation Management Team

NRC · NASDAQ
MJ

Ms. Jordan N. Freeman

Chief Accounting Officer

Born 1988(Age 38)
female
MA

Mr. Andrew Monnich

Chief Corporate Development Officer

Born 1976(Age 50)
male
MJ

Mr. Jon Boumstein

Chief Delivery Officer

male
MJ

Ms. Jennifer Baron

Chief Experience Officer

female
MH

Ms. Helen L. Hrdy

Chief Operating Officer

Compensation

$407,886

Born 1965(Age 61)
female
MV

Ms. Vinitha Ramnathan

Chief Product Officer

female
MM

Mr. Michael D. Hays

Founder, Chief Executive Officer, President, Principal Financial Officer & Director

Compensation

$129,862

Born 1955(Age 71)
male
MC

Megan Charko

Senior Manager of Content Marketing

nrc

National Research Corporation Insider Positioning

NRC · NASDAQ

During the last 12 months, insiders have purchased $896K worth of NRC shares, with no selling activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

8.0K

98.16K

Sold

0

0.00

Net Activity

+98K

+$98K

6-9 Months

Bought

67.9K

788.03K

Sold

0

0.00

Net Activity

+788K

+$788K

9-12 Months

Bought

771

10.00K

Sold

0

0.00

Net Activity

+10K

+$10K

Top Buyers

1
WPA

Wheeler Penny Ann

Director

22.6K shares1 transactions

$263K

2
BDM

Berwick Donald M

Director

22.6K shares1 transactions

$263K

3
NJN

Nunnelly John N

Director

22.6K shares1 transactions

$263K

4
HSR

Harrison Shane R

Officer: Evp & Chief Financial Officer

8.0K shares1 transactions

$98K

5
FJN

Freeman Jordan Nicole

Officer: Chief Accounting Officer

771 shares1 transactions

$10K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $896K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Insider Participation

High Buying

5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.

SEC Filings

NRC - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

May 08, 2026
June 23, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 10, 2025
May 07, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 11, 2024
May 08, 2024
2024
DEF 14A

DEF 14A

N/A

April 06, 2023
April 06, 2023
 
DEF 14A

DEF 14A 2022

N/A

April 07, 2022
May 18, 2022
2022
DEF 14A

DEF 14A 2021

N/A

June 03, 2021
June 29, 2021
2021
DEF 14A

DEF 14A 2020

N/A

April 07, 2020
May 18, 2020
2020
DEF 14A

DEF 14A 2019

N/A

April 09, 2019
May 29, 2019
2019
DEF 14A

DEF 14A 2018

N/A

April 27, 2018
May 30, 2018
2018
DEF 14A

DEF 14A 2018

N/A

March 13, 2018
April 16, 2018
2018
Showing 1 to 10 of 30 filings